The effect of dietary fiber (oat bran) supplement on blood pressure in patients with essential hypertension: A randomized controlled trial

Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2458-2470. doi: 10.1016/j.numecd.2021.04.013. Epub 2021 Apr 28.

Abstract

Background and aims: Insufficient dietary fiber (DF) intake is associated with increased blood pressure (BP) and the mode of action is unclear. The intake of DF supplements by participants in previous interventional studies was still far below the amount recommended by the World Health Organization. Therefore, this study aims to explore the effect of supplementing relatively sufficient DF on BP and gut microbiota in patients with essential hypertension (HTN).

Methods and results: Fifty participants who met the inclusion criteria were randomly divided into the DF group (n = 25) and control group (n = 25). All the participants received education on regular dietary guidance for HTN. In addition to dietary guidance, one bag of oat bran (30 g/d) supplement (containing DF 8.9 g) was delivered to the DF group. The office BP (oBP), 24 h ambulatory blood pressure, and gut microbiota were measured at baseline and third month. After intervention, the office systolic blood pressure (oSBP; P < 0.001) and office diastolic blood pressure (oDBP; P < 0.028) in the DF group were lower than those in the control group. Similarly, the changes in 24hmaxSBP (P = 0.002), 24hmaxDBP (P = 0.001), 24haveSBP (P < 0.007), and 24haveDBP (P = 0.008) were greater in the DF group than in the control group. The use of antihypertensive drugs in the DF group was significantly reduced (P = 0.021). The β diversity, including Jaccard (P = 0.008) and Bray-Curtis distance (P = 0.004), showed significant differences (P < 0.05) between two groups by the third month. The changes of Bifidobacterium (P = 0.019) and Spirillum (P = 0.006) in the DF group were significant.

Conclusions: Increased DF (oat bran) supplement improved BP, reduced the amount of antihypertensive drugs, and modulated the gut microbiota.

Trial registration number: ChiCTR1900024055.

Keywords: Ambulatory blood pressure; Blood pressure; Dietary fiber; Essential hypertension; Gut microbiota.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Avena*
  • Bifidobacterium / growth & development*
  • Blood Pressure Monitoring, Ambulatory
  • Blood Pressure*
  • China
  • Dietary Fiber / administration & dosage*
  • Dysbiosis
  • Edible Grain*
  • Essential Hypertension / diagnosis
  • Essential Hypertension / diet therapy*
  • Essential Hypertension / microbiology
  • Essential Hypertension / physiopathology
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Male
  • Middle Aged
  • Nutritive Value
  • Prospective Studies
  • Spirillum / growth & development*
  • Time Factors
  • Treatment Outcome

Substances

  • Dietary Fiber